Publication at First Faculty of Medicine, Second Faculty of Medicine |
2019
Abstract
Angiotensin-converting enzyme inhibitor-induced angioedema is a rare but dangerous adverse effect. In our case report we describe a successful use of the recombinant human C1 inhibitor for the acute angioedema treatment in a patient with this diagnosis.